QSYMIA
Peakphentermine and topiramate
NDAORALCAPSULE, EXTENDED RELEASE
Approved
Jul 2012
Lifecycle
Peak
Competitive Pressure
8/100
Clinical Trials
1
Mechanism of Action
Cytochrome P450 3A4 Inducers
Clinical Trials (1)
Phase IV Study of Qsymia in Obese Patients
Started Sep 2021
232 enrolled
Obesity
Loss of Exclusivity
LOE Date
Jun 14, 2029
39 months away
Patent Expiry
Jun 14, 2029
Exclusivity Expiry
Sep 13, 2027